Letter by Kruszelnicka et al regarding article, "evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs"

Circulation. 2015 Oct 27;132(17):e212. doi: 10.1161/CIRCULATIONAHA.115.015383.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects*
  • Arginine / analogs & derivatives*
  • Cardiovascular Diseases / blood*
  • Cyclooxygenase 2 / deficiency*
  • Cyclooxygenase 2 Inhibitors / adverse effects*
  • Female
  • Humans
  • Male

Substances

  • Anti-Inflammatory Agents
  • Cyclooxygenase 2 Inhibitors
  • Arginine
  • Cyclooxygenase 2